• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在糖尿病玻璃体切除术中行巩膜光凝术至锯齿缘以预防复发性玻璃体积血。

Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.

机构信息

Department of Ophthalmology, Hallym University Chuncheon Sacred Heart Hospital, Hallym University Medical Center, Chuncheon, Korea.

JC Bit Somang Eye Clinic, Seoul, Korea.

出版信息

Korean J Ophthalmol. 2023 Dec;37(6):477-484. doi: 10.3341/kjo.2023.0066. Epub 2023 Oct 25.

DOI:10.3341/kjo.2023.0066
PMID:37899285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10721404/
Abstract

PURPOSE

To evaluate the role of performing photocoagulation up to ora serrata during vitrectomy in preventing recurrent vitreous hemorrhage (VH) in patients undergoing pars plana vitrectomy (PPV) for proliferative diabetic retinopathy (PDR).

METHODS

This retrospective, nonrandomized study included 60 eyes from 60 patients who had undergone PPV for VH due to PDR. These patients were divided into two groups: group 1, those who underwent photocoagulation up to ora serrata using the scleral indentation technique during surgery; and group 2, those who did not undergo scleral indentation when photocoagulation and underwent photocoagulation up to vortex veins. Their hospital records were analyzed to investigate the recurrence rate of VH, the time until recurrence of VH after surgery, logarithm of the minimal angle of resolution (logMAR) best-corrected visual acuity (BCVA) measured before surgery and at 1, 2, and 3 years after surgery, and the occurrence of complications such as neovascular glaucoma (NVG) during follow-up.

RESULTS

Group 1 exhibited lower recurrence rate of VH (2 of 30 [6.7%] vs. 10 of 30 [33.3%], p = 0.01) and lower occurrence of postoperative NVG (2 of 30 [6.7%] vs. 8 of 30 [26.7%], p = 0.038) compared with group 2. There were no statistically significant differences in logMAR BCVA measured at 1, 2, and 3 years between the two groups (at 1 year: 0.54 ± 0.43 vs. 0.54 ± 0.44, p = 0.954; at 2 years: 0.48 ± 0.47 vs. 0.55 ± 0.64, p = 0.235; at 3 years: 0.51 ± 0.50 vs. 0.61 ± 0.77, p = 0.200). Logistic regression analysis showed that among several factors that could affect recurrence rate of VH, only range of photocoagulation performed was a statistically significant factor (odds ratio, 0.119; 95% confidence interval, 0.022-0.659; p = 0.015).

CONCLUSIONS

Photocoagulation treatment over a wider range with scleral indentation could be a beneficial adjunct procedure for preventing postoperative recurrent VH following diabetic vitrectomy.

摘要

目的

评估在玻璃体切除术中行巩膜扣压式光凝术至锯齿缘的作用,以预防增殖性糖尿病视网膜病变(PDR)患者行玻璃体切除术(PPV)后发生复发性玻璃体积血(VH)。

方法

本回顾性、非随机研究纳入了 60 例因 PDR 所致 VH 而行 PPV 的患者的 60 只眼。这些患者分为两组:组 1 为术中采用巩膜压陷技术行巩膜扣压式光凝术至锯齿缘的患者;组 2 为未行巩膜压陷时行光凝术且光凝至涡静脉的患者。分析其住院病历,以调查 VH 复发率、术后 VH 复发时间、术前及术后 1、2 和 3 年时最小分辨角对数(logMAR)最佳矫正视力(BCVA)、随访期间新生血管性青光眼(NVG)等并发症的发生情况。

结果

与组 2 相比,组 1 的 VH 复发率较低(2/30[6.7%] vs. 10/30[33.3%],p=0.01),术后 NVG 的发生率较低(2/30[6.7%] vs. 8/30[26.7%],p=0.038)。两组患者在术后 1、2 和 3 年时的 logMAR BCVA 测量值无统计学差异(术后 1 年:0.54±0.43 比 0.54±0.44,p=0.954;术后 2 年:0.48±0.47 比 0.55±0.64,p=0.235;术后 3 年:0.51±0.50 比 0.61±0.77,p=0.200)。Logistic 回归分析显示,在可能影响 VH 复发率的多个因素中,仅光凝范围是一个有统计学意义的因素(比值比,0.119;95%置信区间,0.022-0.659;p=0.015)。

结论

在糖尿病玻璃体切除术中行巩膜扣压式光凝术并扩大光凝范围可能是一种有益的辅助手术,有助于预防术后复发性 VH。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7192/10721404/87fd0cd15b40/kjo-2023-0066f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7192/10721404/0a8cc974e4ef/kjo-2023-0066f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7192/10721404/83d2014f6c1b/kjo-2023-0066f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7192/10721404/87fd0cd15b40/kjo-2023-0066f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7192/10721404/0a8cc974e4ef/kjo-2023-0066f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7192/10721404/83d2014f6c1b/kjo-2023-0066f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7192/10721404/87fd0cd15b40/kjo-2023-0066f3.jpg

相似文献

1
Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.在糖尿病玻璃体切除术中行巩膜光凝术至锯齿缘以预防复发性玻璃体积血。
Korean J Ophthalmol. 2023 Dec;37(6):477-484. doi: 10.3341/kjo.2023.0066. Epub 2023 Oct 25.
2
Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.增生型糖尿病视网膜病变伴玻璃体积血 25G 玻璃体切割术后新生血管性青光眼的危险因素:一项回顾性多中心研究。
Sci Rep. 2019 Oct 16;9(1):14858. doi: 10.1038/s41598-019-51411-6.
3
Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy.早期与延迟玻璃体切除术治疗增生性糖尿病视网膜病变继发玻璃体积血
Am J Ophthalmol. 2025 Feb;270:237-244. doi: 10.1016/j.ajo.2024.10.019. Epub 2024 Oct 28.
4
High BMI, silicone oil tamponade, and recurrent vitreous hemorrhage predict poor visual outcomes after pars plana vitrectomy in proliferative diabetic retinopathy.高体重指数、硅油填充和复发性玻璃体出血预示着增殖性糖尿病视网膜病变行玻璃体切割术后视力预后较差。
BMC Ophthalmol. 2025 Mar 19;25(1):148. doi: 10.1186/s12886-025-03954-8.
5
Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.内切开联合光凝治疗增殖性糖尿病视网膜病变行玻璃体切割术后巩膜切口血管化。
Retina. 2012 Jul;32(7):1310-5. doi: 10.1097/IAE.0b013e318236e7ef.
6
Clinical Characteristics and Surgical Outcomes of Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy.增生型糖尿病视网膜病变行玻璃体切除术患者的临床特征和手术结果。
Ophthalmol Retina. 2024 Aug;8(8):823-831. doi: 10.1016/j.oret.2024.02.015. Epub 2024 Mar 4.
7
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.玻璃体积血患者增生性糖尿病视网膜病变中玻璃体内注射阿柏西普与全视网膜光凝联合玻璃体切除术对视力的影响:一项随机临床试验。
JAMA. 2020 Dec 15;324(23):2383-2395. doi: 10.1001/jama.2020.23027.
8
Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.玻璃体内注射阿柏西普联合全视网膜光凝与早期玻璃体切除术治疗糖尿病性玻璃体积血:随机临床试验。
BMC Ophthalmol. 2020 Apr 6;20(1):130. doi: 10.1186/s12886-020-01401-4.
9
A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.增生型糖尿病视网膜病变玻璃体切除术后应用黏弹剂预防玻璃体积血复发的初步研究。
BMC Ophthalmol. 2022 Dec 22;22(1):509. doi: 10.1186/s12886-022-02666-7.
10
Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.填塞在伴有玻璃体积血的增殖性糖尿病视网膜病变玻璃体切除术中的作用
Semin Ophthalmol. 2017;32(4):488-491. doi: 10.3109/08820538.2015.1120757. Epub 2016 Apr 29.

本文引用的文献

1
Risk Factors for Recurrent Vitreous Hemorrhage in Type 2 Diabetes Mellitus Patients after Posterior Vitrectomy.2型糖尿病患者玻璃体切除术后复发性玻璃体出血的危险因素
J Clin Med. 2023 Apr 20;12(8):2989. doi: 10.3390/jcm12082989.
2
A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.增生型糖尿病视网膜病变玻璃体切除术后应用黏弹剂预防玻璃体积血复发的初步研究。
BMC Ophthalmol. 2022 Dec 22;22(1):509. doi: 10.1186/s12886-022-02666-7.
3
Case-matched comparison of vitrectomy, peripheral retinal endolaser, and endocyclophotocoagulation versus standard care in neovascular glaucoma.
玻璃体切除术、周边视网膜激光光凝术和睫状体光凝术与标准治疗相比治疗新生血管性青光眼的病例匹配对照研究
Retina. 2015 Jun;35(6):1072-83. doi: 10.1097/IAE.0000000000000449.
4
Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.糖尿病玻璃体切除术后复发性玻璃体出血患者的超广角荧光素血管造影结果
Invest Ophthalmol Vis Sci. 2014 Oct 8;55(11):7040-6. doi: 10.1167/iovs.14-15112.
5
Comparison of the 20-gauge conventional vitrectomy technique with the 23-gauge releasable suture vitrectomy technique.20号传统玻璃体切除术技术与23号可松解缝线玻璃体切除术技术的比较。
Korean J Ophthalmol. 2013 Feb;27(1):12-8. doi: 10.3341/kjo.2013.27.1.12. Epub 2013 Jan 9.
6
Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.增生型糖尿病视网膜病变玻璃体切割术后玻璃体积血的原因及处理。
Curr Eye Res. 2010 Apr;35(4):308-13. doi: 10.3109/02713680903572491.
7
Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy.糖尿病性玻璃体切除术中残留玻璃体皮质清除在预防术后玻璃体出血中的作用。
Int Ophthalmol. 2010 Apr;30(2):137-42. doi: 10.1007/s10792-009-9298-7. Epub 2009 Jan 25.
8
Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.玻璃体内长效气体在预防糖尿病性玻璃体切除术后早期玻璃体出血中的应用
Ophthalmology. 2007 Apr;114(4):710-5. doi: 10.1016/j.ophtha.2006.07.047. Epub 2007 Feb 2.
9
Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study.糖尿病玻璃体切除术中视网膜前部和巩膜切开部位的冷冻疗法预防复发性玻璃体出血:一项超声生物显微镜研究
Ophthalmology. 2005 Dec;112(12):2095-102. doi: 10.1016/j.ophtha.2005.07.010. Epub 2005 Oct 12.
10
Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings.糖尿病性视网膜病变行玻璃体切除术后复发性玻璃体出血患者巩膜切开处的纤维血管内生:超声生物显微镜检查结果
Ophthalmology. 2004 Jun;111(6):1215-21. doi: 10.1016/j.ophtha.2003.08.043.